Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDuke Capital Regulatory News (DUKE)

Share Price Information for Duke Capital (DUKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.25
Bid: 32.00
Ask: 32.50
Change: -0.75 (-2.27%)
Spread: 0.50 (1.563%)
Open: 32.50
High: 32.75
Low: 32.25
Prev. Close: 33.00
DUKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Long Term Incentive Plan Awards

29 Oct 2021 16:03

RNS Number : 7845Q
Duke Royalty Limited
29 October 2021
 

29 October 2021

 

Duke Royalty Limited

("Duke Royalty", "Duke" or the "Company")

Long Term Incentive Plan ("LTIP") Awards

Issue of Equity

Director/PDMR Dealings

 

New grant under LTIP

 

Duke Royalty Limited (AIM: DUKE), a provider of alternative capital solutions to a diversified range of profitable and long-established businesses in Europe and abroad, announces that the Company's Remuneration Committee has approved the grant of a total of 2,108,000 conditional rights to acquire ordinary shares of no par value ("Performance Share Awards" or "PSAs") under the Company's Long-Term Incentive Plan ("LTIP"). The LTIP framework was detailed within the Company's admission document which was published on 20 March 2017 and was put into place post Admission.

 

PSAs for the financial year to 31 March 2021 have been granted are as follows:

 

Neil Johnson

470,500

Charlie Cannon Brookes

423,500

Other employees (non-PDMRs)

1,214,000

Total

2,108,000

 

The PSAs vest after a period of three years and are subject to various performance conditions outlined in the Company's admission document (and available on the Company's website) and set by the Remuneration Committee, all in accordance with the LTIP rules. The LTIP Awards will be subject to performance conditions, (50 per cent. based on growth in total shareholder return ("TSR") and 50 per cent. on growth in total cash available for distribution per share ("TCAD per Share")). TSR can be defined as the returns generated by shareholders based on the combined value of the dividends paid out by the Company and the share price performance over the period in question.

 

Vesting of 2018 PSAs, transfer from EBT & Director/PDMR interests

 

The Company also announces that a total of 1,456,875 PSAs previously granted under the Company's 2018 LTIP award have vested, representing 87.5% of the PSAs granted at that time.

 

Of these 1,456,875 existing ordinary shares issued, which have now been transferred to the beneficiaries, 250,000 have been sold at a price of 41.54 pence in order to meet certain tax liabilities arising upon issue of the PSAs, with the balance of the New Ordinary Shares being retained by the participants in accordance with the terms of the Scheme. Further information is set out within the PDMR notification tables below.

 

Following the various transactions detailed above, the following Directors / PDMRs have the following total interest in ordinary shares and options:

 

 

Director/PDMR

Total ordinary shares held

Total shares under option (3)

Neil Johnson (1)

4,741,673

2,820,500

Charlie Cannon Brookes (2)

6,717,530

2,650,000

 

 

(1) Mr Johnson is Abingdon Capital Corporation's sole voting shareholder which legally owns 1,834,223 ordinary shares included within this figure.

 

(2) Mr Cannon Brookes is the investment director and shareholder of Arlington Asset Management Limited ("Arlington"). This figure includes 3,000,000 ordinary shares legally owned by Arlington.

 

(3) Includes PSAs under the Company's LTIP.

 

 

Total voting rights and EBT shares

 

In order to maintain an appropriate level of headroom within the Company's EBT, the Company has issued 791,875 new ordinary shares into the Duke Royalty Employee Benefit Trust ("EBT"), ownership of which shall be transferred, in part or in full, to individual beneficiaries, subject to achievement of the performance criteria following the vesting period. Application has been made for these 791,875 shares to be admitted to trading on AIM, which is expected to occur on 1 November 2021 ("Admission").

 

Following Admission and transfer of the 791,875 shares to LTIP beneficiaries, the Company will have 358,803,360 ordinary shares in issue admitted to trading on AIM, of which 10,190,000 will be held by the EBT. This figure (358,803,360) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

For further information, please visit www.dukeroyalty.com, or contact: 

 

 

Duke Royalty Limited

Neil Johnson / Charlie Cannon Brookes / Hugo Evans

 

+44 (0) 1481 730 613

Cenkos Securities plc 

(Nominated Adviser and Joint Broker)

 

Stephen Keys / Callum Davidson / Julian Morse 

 

+44 (0) 207 397 8900

Canaccord Genuity

(Joint Broker)

 

Adam James / Georgina McCooke

+44 (0) 207 523 8000

SEC Newgate (PR)

Elisabeth Cowell/Richard Bicknell/ Megan Kovach

+44 (0) 20 3757 6880 

 dukeroyalty@secnewgate.co.uk

 

 

Notifications of dealings by PDMRs:

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Royalty Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value

GG00BYZSSY63

b)

Nature of transaction

Grant of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

470,500

d)

Aggregated Information

n/a

e)

Date of transaction

Award date 29 October 2021

f)

Place of transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Royalty Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value

GG00BYZSSY63

b)

Nature of transaction

Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

743,750

d)

Aggregated Information

n/a

e)

Date of transaction

29 October 2021

f)

Place of transaction

Outside a trading venue

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Neil Johnson

2.

Reason for notification

a)

Position/Status

Chief Executive Officer

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Royalty Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value

GG00BYZSSY63

b)

Nature of transaction

Sale of ordinary shares following vesting of conditional performance share awards under LTIP to cover tax liability

c)

Price(s) and volume(s)

Price(s)

Volume(s)

41.54p per share

250,000

d)

Aggregated Information

n/a

e)

Date of transaction

29 October 2021

f)

Place of transaction

Outside a trading venue

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Charlie Cannon Brookes

2.

Reason for notification

a)

Position/Status

Executive Director

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Royalty Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value

GG00BYZSSY63

b)

Nature of transaction

Grant of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

423,500

d)

Aggregated Information

n/a

e)

Date of transaction

Award date 29 October 2021

f)

Place of transaction

Outside a trading venue

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Charlie Cannon Brookes

2.

Reason for notification

a)

Position/Status

Executive Director

b)

Initial notification/amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Duke Royalty Limited

b)

LEI

213800GUTKPSJ39SER44

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of nil par value

GG00BYZSSY63

b)

Nature of transaction

Acquisition of ordinary shares following vesting of conditional performance share awards under LTIP

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

525,000

d)

Aggregated Information

n/a

e)

Date of transaction

29 October 2021

f)

Place of transaction

Outside a trading venue

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHDKCBPQBDDCKB
Date   Source Headline
20th Apr 20215:22 pmRNSHolding(s) in Company
20th Apr 20215:19 pmRNSHolding(s) in Company
20th Apr 20214:19 pmRNSHolding(s) in Company
19th Apr 202112:30 pmRNSDirector / PCA Dealings
19th Apr 20217:00 amRNSSuccessful Exit of Investment in Royalty Partner
16th Apr 20213:14 pmRNSResult of General Meeting and Issue of Equity
6th Apr 20215:17 pmRNSResult of PrimaryBid Offer and Total Voting Rights
1st Apr 20217:00 amRNSResult of Placing
31st Mar 20214:32 pmRNSPrimaryBid Offer
31st Mar 20214:30 pmRNSPlacing to raise a minimum of £30 million
31st Mar 20214:30 pmRNSExit of Investment into Royalty Partner
18th Mar 20217:00 amRNSIncreased Interim Dividend & Dividend Declaration
15th Mar 20217:00 amRNSIncreased £35 Million Revolving Credit Facility
12th Mar 20217:00 amRNSHolding(s) in Company
10th Mar 20217:00 amRNSHolding(s) in Company
1st Mar 20212:05 pmRNSSecond Price Monitoring Extn
1st Mar 20212:00 pmRNSPrice Monitoring Extension
1st Mar 20217:00 amRNSFollow-on investment into existing royalty partner
19th Feb 20217:00 amRNSHolding(s) in Company
16th Feb 20217:00 amRNSNew Royalty Partner
9th Feb 20212:36 pmRNSHolding(s) in Company
4th Feb 20217:00 amRNSTrading Update
22nd Jan 202111:44 amRNSHolding(s) in Company
14th Jan 20217:00 amRNSFollow-on investment into existing Royalty Partner
11th Jan 20217:00 amRNSAppointment of Chief Investment Officer
24th Dec 20207:00 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:01 amRNSFollow-on investment into existing royalty partner
22nd Dec 20207:00 amRNSExit of Investment in Royalty Partner
9th Dec 20207:01 amRNSInterim Results
9th Dec 20207:00 amRNSReinstated Cash Dividend and Dividend Declaration
18th Nov 20207:01 amRNSInvestor Presentation
18th Nov 20207:00 amRNSNotice of Interim Results
12th Nov 20209:05 amRNSSecond Price Monitoring Extn
12th Nov 20209:00 amRNSPrice Monitoring Extension
12th Nov 20207:00 amRNSTrading Update and Reinstatement of Cash Dividend
21st Oct 20202:34 pmRNSResult of Annual General Meeting
21st Oct 20207:00 amRNSAppointment of Joint Broker
15th Oct 20205:35 pmRNSHolding(s) in Company
14th Oct 20201:00 pmRNSDirector/PDMR Dealings
2nd Oct 20203:47 pmRNSIssue of Equity for Scrip Dividend
2nd Oct 202012:39 pmRNSLTIP, Issue of Equity, Director/PDMR Holdings
1st Oct 20201:25 pmRNSScrip Dividend Reference Price
25th Sep 20207:00 amRNSPosting of Report and Accounts and Notice of AGM
17th Sep 20207:01 amRNSFinancial 2020 Final Results
17th Sep 20207:00 amRNSDividend Declaration
16th Sep 20207:00 amRNSTrading Update
14th Sep 20207:00 amRNSSuccessful Exit of Investment in Royalty Partner
10th Aug 20207:00 amRNSHolding(s) in Company
10th Aug 20207:00 amRNSFollow-on investment into existing royalty partner
6th Aug 20207:00 amRNSTrading Update and Notice of FY 2020 Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.